SciSight Ecosystem
WoS ESCI Q3Scopus Q3SCImago #10,768CAS 4区Diamond OAGold OA

Journal of the Egyptian National Cancer Institute

Country: United Kingdom•WoS SCIE Quartile: Q3•Scopus SJR: 0.551•SCImago Rank: #10,768•Identifier (ISSN):1110-0362(Print)/2589-0409(Online)•Articles / Year: 38•Estimated Publication Fee (APC): Free (Diamond OA)
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)Q3
2.2
↑ +0.4

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (Hirsch Index)
33

33 papers with at least that number of citations each

WoS: ESCIQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
38articles/year
100% Gold OA•77.19% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q3(IF: 2.2)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.50đ
WoS Q3(IF: 2.2)
🔵 Computed
20251.50đ
WoS Q3(IF: 1.8)
🔵 Computed
20241.50đ
WoS Q3(IF: 2.1)
🔵 Computed
20231.50đ
WoS Q3(IF: 1.8)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

As the official publication of the National Cancer Institute, Cairo University, the Journal of the Egyptian National Cancer Institute (JENCI) is an open access peer-reviewed journal that publishes on the latest innovations in oncology and thereby, providing academics and clinicians a leading research platform. JENCI welcomes submissions pertaining to all fields of basic, applied and clinical cancer research. Main topics of interest include: local and systemic anticancer therapy (with specific interest on applied cancer research from developing countries); experimental oncology; early cancer detection; randomized trials (including negatives ones); and key emerging fields of personalized medicine, such as molecular pathology, bioinformatics, and biotechnologies.

Topics Covered (Recognized by AI)
MedicineBiology95.4%Internal medicine94%Genetics88.6%Pathology70.2%Surgery62%Cancer60.8%Radiology44.4%Immunology40.2%Oncology38.8%Chemistry38%Biochemistry31.9%Cancer research24.4%Mathematics23.6%Chemotherapy23.3%Radiation therapy22.5%Breast cancer21.5%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,768Scopus Q3Diamond OASCImago Profile
Scopus Coverage:2005-2009, 2011-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q3
0.551

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q3
Scopus H-Index (2025)
33

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
2.45

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
100% Free

Diamond Open Access: Authors publish completely free of charge with zero author-facing fees.

Diamond Open Access

Scopus 3-Year Publication & Citation Window

3-Year Citations370
3-Year Documents145
Citable Documents145

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ3
Cancer ResearchQ4

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Gold OA
OA publishing option or traditional subscription
Publisher
SpringerOpen
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusDOAJPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ONCOLOGY
JCRESCI
228/333Q3
ONCOLOGY
JCIESCI
253/333Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
20251.87247
20242.144103
20231.844211
2022—57430
2021—40471
2020—44767
2019—12148
2018—29343
2017—34359
2016—38687
2015—44678
2014—29334
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Journal of the Egyptian National Cancer Institute

WoS Q3
12232023202420251.80
Annual Impact Factor Metric
2025:1.8

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: b5d8d7da-a866-4422-b8e2-054d2679cc8a
Database Updated: 2026-10-01